
Endocrine and metabolic aspects of the management of patients undergoing bariatric surgery. Review of clinical recommendations.
Author(s) -
Н. В. Мазурина,
М А Свиридонова
Publication year - 2012
Publication title -
ožirenie i metabolizm
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.154
H-Index - 5
eISSN - 2306-5524
pISSN - 2071-8713
DOI - 10.14341/2071-8713-5060
Subject(s) - guideline , medicine , endocrine system , incidence (geometry) , obesity , morbid obesity , intensive care medicine , general surgery , surgery , endocrine surgery , sleeve gastrectomy , obesity surgery , weight loss , hormone , gastric bypass , pathology , physics , thyroid , optics
The incidence of morbid obesity increases worldwide. Therefore surgical methods of treatment are widely applied. A lot of patients after bariatric surgery requires lifelong control and therapy. The Endocrine Society offered detailed guideline for the management of boost-bariatric surgery patients. The basic recommendations are reviewed in this article.